Activity of Aryl Hydrocarbon Hydroxylase in Psoriatic Skin
Overview
Authors
Affiliations
The activity of aryl hydrocarbon hydroxylase (A.H.H.), a microsomal mono-oxygenase, was reduced in epidermis from both the psoriatic lesions and clinically normal lesion-free skin from psoriatic patients. Induction of epidermal A.H.H. activity by benzanthracene was also significantly less than normal in both psoriatic lesions and in clinically normal skin from patients with psoriasis. The enzyme defect may be related to the primary genetic abnormality of the disease.
Basal cell carcinoma in psoriasis.
Powell F, Mackey J Ir J Med Sci. 2016; 148(1):276.
PMID: 27517436 DOI: 10.1007/BF02938098.
Coal tar therapy. Is it carcinogenic?.
Schooten F, Godschalk R Drug Saf. 1996; 15(6):374-7.
PMID: 8968692 DOI: 10.2165/00002018-199615060-00002.
Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis.
Chapman P, Kersey P, Keys B, Shuster S, Rawlins M Br Med J. 1980; 281(6251):1315-6.
PMID: 7437778 PMC: 1714719. DOI: 10.1136/bmj.281.6251.1315.
A new animal model for the study of cutaneous drug-metabolizing enzymes.
Goerz G, Berger H, Tsambaos D Arch Dermatol Res. 1981; 270(3):367-9.
PMID: 6973956 DOI: 10.1007/BF00403942.
Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis.
Chapman P, Rawlins M, Shuster S, Idle J, Ritchie J, Smith R Eur J Clin Pharmacol. 1981; 21(3):257-8.
PMID: 6895622 DOI: 10.1007/BF00627929.